Hsa-miR-196a2 Functional SNP is Associated With Severe Toxicity After Platinum-Based Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients in a Chinese Population

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 6, 2012, Pages 441-446

  Zhan, Xiaoying ^a   Wu, Wenting ^b,e   Han, Baohui ^c   Gao, Ge ^b   Qiao, Rong ^c   Lv, Juan ^b   Zhang, Shuyu ^b   Zhang, Wei ^c   Fan, Weiwei ^b   Chen, Hongyan ^b   Zhang, Tianbao ^d   Gu, Aiqin ^c   Shen, Jie ^c   Wu, Qihan ^a   Lu, Daru ^b  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carboplatin; Chemotherapeutics; Cisplatin; MicroRNA; Prognosis; Rs11614913; Side effect

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; MICRORNA; NAVELBINE; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CHINESE; FEMALE; GASTROINTESTINAL TOXICITY; HOMOZYGOSITY; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PLATINUM COMPOUNDS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869017808     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21544     Document Type: Article

References (29)

1. Stanley K, Stjernsward J. Lung cancer - A worldwide health problem. Chest 1989;96(1):S1-S5.
2. Cosaert J, Quoix E. Platinum drugs in the treatment of non-small-cell lung cancer. Br J Cancer 2002;87(8):825-833.
3. Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 1998;4(5):1087-1100.
4. Mendell JT. MicroRNAs - Critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005;4(9):1179-1184.
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-297.
6. Valencia-Sanchez MA, Liu JD, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20(5):515-524.
7. Yonaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9(3):189-198.
8. Calin GA, Croce CM. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006;66(15):7390-7394.
9. Duan RH, Pak CH, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. HumMol Genet 2007;16(9):1124-1131.
10. Hu ZB, Chen JP, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008;118(7):2600-2608.
11. Tian T, Shu YQ, Chen JP, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptiblility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009;18(4):1183-1187.
12. Hu ZB, Liang J, Wang ZW, et al. Common genetic variants in Pre-MicroRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009;30(1):79-84.
13. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297(17):1901-1908.
14. Zhu L, Chu H, Gu D, et al. A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol 2012;31(3):350-354.
15. Okubo M, Tahara T, Shibata T, et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010;15(6):524-531.
16. Chu H, Wang M, Shi D, et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 2011;6:e18108.
17. Wu WT, Zhang W, Qiao R, et al. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin Cancer Res 2009;15(11):3889-3895.
18. Jurinke C, Boom D van den, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Method Mol Biol 2001;170:103-116.
19. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. MicroRNA-196: Critical roles and clinical applications in development and cancer. J Cell Mol Med 2011;15:14-23.
20. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297:1901-1908.
21. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008;54:1716-1724.
22. Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009;2:807-813.
23. Wang Y, Li Z, He C, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis 2010;44:191-197.
24. Niinuma T, Suzuki H, Nojima M, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012;72(5):1126-1136.
25. Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010;16:3713-3720.
26. Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger Y. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study. J Viral Hepat 2011;18:e399-e407.
27. Dou T, Wu Q, Chen X, et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 2010;136:1853-1859.
28. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008;27(52):6667-6678.
29. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004;304(5670):594-596.